Suchergebnisse - "Buti, Maria"

PubPharm (73)

41

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response

enthalten in: PloS one | 2017

von Asselah, T. | Moreno, C. | Sarrazin, C. | +12

42

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies : The Preblin study

enthalten in: PloS one | 2017

von Buti, M. | Manzano, M. | Morillas, R. | +15

ErratumIn: PLoS One. 2018 Jun 25;13(6):e0199926. - PMID 29940039

43

Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection

enthalten in: Gastroenterology | 2017

von Kwo, P. | Gane, E. | Peng, C. | +15

44

Flares during long-term entecavir therapy in chronic hepatitis B

enthalten in: Journal of gastroenterology and hepatology | 2016

von Chi, H. | Arends, P. | Reijnders, J. | +19

45

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection : a randomised, double-blind, phase 3, non-inferiority trial

enthalten in: The lancet. Gastroenterology & hepatology | 2016

von Buti, M. | Gane, E. | Seto, W. | +20

CommentIn: Lancet Gastroenterol Hepatol. 2016 Nov;1(3):174-175. - PMID 28404084

46

Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting : The MENTE Study

enthalten in: Journal of clinical gastroenterology | 2016

von Rodríguez-Nóvoa, S. | García-Samaniego, J. | Prieto, M. | +19

47

Short article : Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study

enthalten in: European journal of gastroenterology & hepatology | 2016

von Zeuzem, S. | Mantry, P. | Soriano, V. | +11

48

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease : a multicentre, open-label, randomised, phase 2 trial

enthalten in: The Lancet. Infectious diseases | 2016

von Manns, M. | Samuel, D. | Gane, E. | +23

CommentIn: Lancet Infect Dis. 2016 Jun;16(6):624-625. - PMID 26907737

49

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

enthalten in: Journal of hepatology | 2016

von Papatheodoridis, G. | Dalekos, G. | Sypsa, V. | +19

50

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

enthalten in: Gastroenterology | 2016

von Marcellin, P. | Ahn, S. | Ma, X. | +28

CommentIn: Gastroenterology. 2016 Jan;150(1):32-4. - PMID 26615120